<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet title="?" type="text/xsl" href="rss.xsl"?>
<rss version="2.0">
<channel>
<title>UBS Research: Healthcare</title>
<link>http://clientportal.ibb.ubs.com/portal/index.jsp?page=eqrschstockrschsector&amp;IndCatCode=HCR&amp;MarketCode=GL&amp;MarketCap=X</link>
<description>UBS Research: Healthcare</description>
<language>en</language>
<copyright>Copyright (C) UBS 2009. All rights reserved.</copyright>
<managingEditor>eMarketing@ubs.com</managingEditor>
<webMaster>eMarketing@ubs.com</webMaster>
<pubDate>Sat, 21 Nov 2009</pubDate>
<lastBuildDate>Sun, 22 Nov 2009</lastBuildDate>
<ttl>60</ttl>
<docs>http://clientportal.ibb.ubs.com/portal/index.jsp?page=eqrschrss</docs>
<image>
<url>http://research.ibb.ubs.com:80/images/logo.gif</url>
<title>UBS</title>
<link>http://www.ubs.com</link>
<width>160</width>
<height>44</height>
</image>
<item>
<title><![CDATA[Sinopharm "Well positioned to leverage industry consolidation [EXTRACT]"]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uev51931|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Asia</li><br><li>China</li><br><li>Asia Pacific</li><br><li>Asia Pacific Ex. JP</li><br></ul><br><em>Sectors</em><br><ul><li>Global Pharmaceuticals</li><br><li>Global Healthcare</li><br><li>Asian Pharmaceuticals</li><br><li>Chinese Pharmaceuticals</li><br><li>Asian Healthcare</li><br><li>Chinese Healthcare</li><br><li>Asian Pacific Pharmaceuticals</li><br><li>Asian Pacific Healthcare</li><br><li>Asian Pacific Ex. JP Pharmaceuticals</li><br><li>Asian Pacific Ex. JP Healthcare</li><br></ul><br><em>Companies</em><br><ul><li>1099.HK Sinopharm</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Initiating Coverage</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Amy Zou</author>
<category>1099.HK</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uev51931|native|public|20091121004606</guid>
<pubDate>Sat, 21 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[US Biotechnology "UBS Biotech Weekly Check-Up: 11/20/09" 20-Nov-2009 Shenouda]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82889|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Biotechnology</li><br><li>Global Healthcare</li><br><li>US Biotechnology</li><br><li>Americas Biotechnology</li><br><li>Americas Healthcare</li><br><li>US Healthcare</li><br><li>North American Biotechnology</li><br><li>North American Healthcare</li><br></ul><br><em>Companies</em><br><ul><li>GENZ.O Genzyme</li><br><li>ITMN.O Intermune</li><br><li>MDCO.O Medicines</li><br></ul><br><em>Subjects</em><br><ul><li>Industry Overview</li><br><li>Market Strategy / Comment</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Maged Shenouda</author>
<category>GENZ.O</category>
<category>ITMN.O</category>
<category>MDCO.O</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82889|native|public|20091120230655</guid>
<pubDate>Fri, 20 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Shandong Weigao "Downgrade on valuation" (Sell) Zou]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uev51938|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Asia</li><br><li>China</li><br><li>Asia Pacific</li><br><li>Asia Pacific Ex. JP</li><br></ul><br><em>Sectors</em><br><ul><li>Global Medical Supplies</li><br><li>Global Healthcare</li><br><li>Global Medical Products</li><br><li>Asian Medical Supplies</li><br><li>Chinese Medical Supplies</li><br><li>Asian Healthcare</li><br><li>Asian Medical Products</li><br><li>Chinese Healthcare</li><br><li>Chinese Medical Products</li><br><li>Asian Pacific Healthcare</li><br><li>Asian Pacific Medical Supplies</li><br><li>Asian Pacific Medical Products</li><br><li>Asian Pacific Ex. JP Healthcare</li><br><li>Asian Pacific Ex. JP Medical Supplies</li><br><li>Asian Pacific Ex. JP Medical Products</li><br></ul><br><em>Companies</em><br><ul><li>8199.HK Shandong Weigao</li><br></ul><br><em>Subjects</em><br><ul><li>Change in Recommendation</li><br><li>Company Update</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Amy Zou</author>
<category>8199.HK</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uev51938|native|public|20091120143813</guid>
<pubDate>Fri, 20 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[European Biotechnology "Weekly Valuation & The Week Ahead" 20-Nov-2009 Wales]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uer70046|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Europe Including UK</li><br><li>Global</li><br></ul><br><em>Sectors</em><br><ul><li>European Biotechnology</li><br><li>Global Biotechnology</li><br><li>European Healthcare</li><br><li>Global Healthcare</li><br></ul><br><em>Companies</em><br><ul><li>GALN.S Galenica</li><br><li>SN.L Smith &amp; Nephew</li><br><li>NOBN.VX Nobel Biocare</li><br><li>SOON.VX Sonova</li><br><li>TECN.S Tecan Group</li><br><li>GDRB.BU Gedeon Richter</li><br><li>GETIb.ST Getinge AB</li><br><li>SHP.L Shire Pharmaceutical</li><br><li>QGEN.F Qiagen</li><br><li>STMN.S Straumann</li><br><li>SYST.VX Synthes Inc</li><br><li>WDH.CO William Demant</li><br><li>LONN.VX Lonza Group</li><br><li>CRCL.AS Crucell</li><br><li>GEN.CO Genmab</li><br><li>ATLN.VX Actelion</li><br><li>BIOX.PA Biomerieux</li><br><li>ELN.I Elan Corp.</li><br><li>FMEG.DE Fresenius Medical</li><br><li>BSLN.S Basilea</li><br><li>ICEL.VI Intercell</li><br><li>DIAS.MI Diasorin</li><br><li>PRON.OL Pronova Biopharma</li><br><li>ROVI.MC Laboratorios Rovi</li><br></ul><br><em>Subjects</em><br><ul><li>Industry Overview</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Martin Wales, PhD</author>
<category>GALN.S</category>
<category>SN.L</category>
<category>NOBN.VX</category>
<category>SOON.VX</category>
<category>TECN.S</category>
<category>GDRB.BU</category>
<category>GETIb.ST</category>
<category>SHP.L</category>
<category>QGEN.F</category>
<category>STMN.S</category>
<category>SYST.VX</category>
<category>WDH.CO</category>
<category>LONN.VX</category>
<category>CRCL.AS</category>
<category>GEN.CO</category>
<category>ATLN.VX</category>
<category>BIOX.PA</category>
<category>ELN.I</category>
<category>FMEG.DE</category>
<category>BSLN.S</category>
<category>ICEL.VI</category>
<category>DIAS.MI</category>
<category>PRON.OL</category>
<category>ROVI.MC</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uer70046|native|public|20091120091107</guid>
<pubDate>Fri, 20 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[European Medtech  "Weekly Valuation & The Week Ahead" 20-Nov-2009 Wales]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uer70037|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Europe Including UK</li><br><li>Global</li><br><li>Americas</li><br></ul><br><em>Sectors</em><br><ul><li>Global Healthcare</li><br><li>Global Medical Products</li><br><li>Americas Healthcare</li><br><li>Americas Medical Products</li><br></ul><br><em>Companies</em><br><ul><li>GALN.S Galenica</li><br><li>FREG_p.DE Fresenius</li><br><li>CLSGn.F Celesio AG</li><br><li>GN.CO GN Great Nordic</li><br><li>SN.L Smith &amp; Nephew</li><br><li>NOBN.VX Nobel Biocare</li><br><li>SOON.VX Sonova</li><br><li>TECN.S Tecan Group</li><br><li>GETIb.ST Getinge AB</li><br><li>SHP.L Shire Pharmaceutical</li><br><li>QGEN.F Qiagen</li><br><li>STMN.S Straumann</li><br><li>SYST.VX Synthes Inc</li><br><li>WDH.CO William Demant</li><br><li>BIOX.PA Biomerieux</li><br><li>ELN.I Elan Corp.</li><br><li>FMEG.DE Fresenius Medical</li><br><li>DIAS.MI Diasorin</li><br></ul><br><em>Subjects</em><br><ul><li>Industry Overview</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Maja S. Pataki</author>
<category>GALN.S</category>
<category>FREG_p.DE</category>
<category>CLSGn.F</category>
<category>GN.CO</category>
<category>SN.L</category>
<category>NOBN.VX</category>
<category>SOON.VX</category>
<category>TECN.S</category>
<category>GETIb.ST</category>
<category>SHP.L</category>
<category>QGEN.F</category>
<category>STMN.S</category>
<category>SYST.VX</category>
<category>WDH.CO</category>
<category>BIOX.PA</category>
<category>ELN.I</category>
<category>FMEG.DE</category>
<category>DIAS.MI</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uer70037|native|public|20091120080051</guid>
<pubDate>Fri, 20 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Cochlear "Advanced Bionics fresh recall" (Buy) Goodsall]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uet11557|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Asia Pacific</li><br><li>Asia Pacific Ex. JP</li><br><li>Australia</li><br><li>Australasia</li><br></ul><br><em>Sectors</em><br><ul><li>Global Advanced Medical Devices</li><br><li>Global Healthcare</li><br><li>Global Medical Products</li><br><li>Asian Pacific Healthcare</li><br><li>Asian Pacific Advanced Medical Devices</li><br><li>Asian Pacific Medical Products</li><br><li>Asian Pacific Ex. JP Healthcare</li><br><li>Asian Pacific Ex. JP Advanced Medical Devices</li><br><li>Asian Pacific Ex. JP Medical Products</li><br><li>Australian Advanced Medical Devices</li><br><li>Australian Healthcare</li><br><li>Australian Medical Products</li><br><li>Australasian Healthcare</li><br><li>Australasian Advanced Medical Devices</li><br><li>Australasian Medical Products</li><br></ul><br><em>Companies</em><br><ul><li>COH.AX Cochlear</li><br></ul><br><em>Subjects</em><br><ul><li>Morning Note</li><br></ul>]]></description>
<author>Andrew Goodsall</author>
<category>COH.AX</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uet11557|native|public|20091120010114</guid>
<pubDate>Fri, 20 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Sinopharm "Well positioned to leverage industry consolidation" (Neutral) Zou]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uev51930|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Asia</li><br><li>China</li><br><li>Asia Pacific</li><br><li>Asia Pacific Ex. JP</li><br></ul><br><em>Sectors</em><br><ul><li>Global Pharmaceuticals</li><br><li>Global Healthcare</li><br><li>Asian Pharmaceuticals</li><br><li>Chinese Pharmaceuticals</li><br><li>Asian Healthcare</li><br><li>Chinese Healthcare</li><br><li>Asian Pacific Pharmaceuticals</li><br><li>Asian Pacific Healthcare</li><br><li>Asian Pacific Ex. JP Pharmaceuticals</li><br><li>Asian Pacific Ex. JP Healthcare</li><br></ul><br><em>Companies</em><br><ul><li>1099.HK Sinopharm</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Initiating Coverage</li><br></ul>]]></description>
<author>Amy Zou</author>
<category>1099.HK</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uev51930|native|public|20091120001300</guid>
<pubDate>Fri, 20 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Cephalon "Lupuzor Still Looks Promising " (Buy) Goodman]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82839|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Pharmaceuticals</li><br><li>Global Healthcare</li><br><li>Americas Pharmaceuticals</li><br><li>US Pharmaceuticals</li><br><li>Americas Healthcare</li><br><li>US Healthcare</li><br><li>North American Pharmaceuticals</li><br><li>North American Healthcare</li><br></ul><br><em>Companies</em><br><ul><li>CEPH.O Cephalon</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Marc Goodman</author>
<category>CEPH.O</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82839|native|public|20091119233334</guid>
<pubDate>Thu, 19 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[F&P Healthcare "1H result - FX impacting, but growth strong" (Buy) Bloom]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uet11550|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Asia Pacific</li><br><li>Asia Pacific Ex. JP</li><br><li>New Zealand</li><br><li>Australasia</li><br></ul><br><em>Sectors</em><br><ul><li>Global Advanced Medical Devices</li><br><li>Global Healthcare</li><br><li>Global Medical Products</li><br><li>Asian Pacific Healthcare</li><br><li>Asian Pacific Advanced Medical Devices</li><br><li>Asian Pacific Medical Products</li><br><li>Asian Pacific Ex. JP Healthcare</li><br><li>Asian Pacific Ex. JP Advanced Medical Devices</li><br><li>Asian Pacific Ex. JP Medical Products</li><br><li>New Zealand Advanced Medical Devices</li><br><li>New Zealand Healthcare</li><br><li>New Zealand Medical Products</li><br><li>Australasian Healthcare</li><br><li>Australasian Advanced Medical Devices</li><br><li>Australasian Medical Products</li><br></ul><br><em>Companies</em><br><ul><li>FPH.NZ F&amp;P Healthcare</li><br><li>RMD.N Resmed</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Operating Results</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Jason Bloom</author>
<category>FPH.NZ</category>
<category>RMD.N</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uet11550|native|public|20091119195210</guid>
<pubDate>Thu, 19 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Johnson & Johnson "EINSTEIN-Extension positive for Xarelto" (Buy) Nudell]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82832|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Advanced Medical Devices</li><br><li>Global Healthcare</li><br><li>Global Medical Products</li><br><li>US Advanced Medical Devices</li><br><li>Americas Advanced Medical Devices</li><br><li>Americas Healthcare</li><br><li>Americas Medical Products</li><br><li>US Healthcare</li><br><li>US Medical Products</li><br><li>North American Healthcare</li><br><li>North American Advanced Medical Devices</li><br><li>North American Medical Products</li><br></ul><br><em>Companies</em><br><ul><li>JNJ.N Johnson &amp; Johnson</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Operating Results</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Bruce Nudell, PhD</author>
<category>JNJ.N</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82832|native|public|20091119171950</guid>
<pubDate>Thu, 19 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Medtronic "F2Q Earnings Preview" (Buy) Nudell]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82836|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Advanced Medical Devices</li><br><li>Global Healthcare</li><br><li>Global Medical Products</li><br><li>US Advanced Medical Devices</li><br><li>Americas Advanced Medical Devices</li><br><li>Americas Healthcare</li><br><li>Americas Medical Products</li><br><li>US Healthcare</li><br><li>US Medical Products</li><br><li>North American Healthcare</li><br><li>North American Advanced Medical Devices</li><br><li>North American Medical Products</li><br></ul><br><em>Companies</em><br><ul><li>MDT.N Medtronic</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Bruce Nudell, PhD</author>
<category>MDT.N</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82836|native|public|20091119164044</guid>
<pubDate>Thu, 19 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[U.S. Specialty Pharmaceuticals "Small Tax Should Not Impact Procedures"]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82824|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Pharmaceuticals</li><br><li>Global Healthcare</li><br><li>Americas Pharmaceuticals</li><br><li>US Pharmaceuticals</li><br><li>Americas Healthcare</li><br><li>US Healthcare</li><br><li>North American Pharmaceuticals</li><br><li>North American Healthcare</li><br></ul><br><em>Companies</em><br><ul><li>TEVA.O Teva Pharmaceuticals</li><br><li>FRX.N Forest Labs</li><br><li>MYL.O Mylan Inc.</li><br><li>WPI.N Watson</li><br><li>CEPH.O Cephalon</li><br><li>SNTS.O Santarus</li><br><li>ENDP.O Endo</li><br></ul><br><em>Subjects</em><br><ul><li>Industry Overview</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Marc Goodman</author>
<category>TEVA.O</category>
<category>FRX.N</category>
<category>MYL.O</category>
<category>WPI.N</category>
<category>CEPH.O</category>
<category>SNTS.O</category>
<category>ENDP.O</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82824|native|public|20091119143049</guid>
<pubDate>Thu, 19 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Straumann "Straumann - performance through excellence " (Sell) Pataki]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uer69968|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Switzerland</li><br><li>Europe Including UK</li><br><li>Europe Ex. UK</li><br><li>Global</li><br><li>UBSW EMEA</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Swiss Medical Supplies</li><br><li>European Medical Supplies</li><br><li>European Ex. UK Medical Supplies</li><br><li>Global Medical Supplies</li><br><li>European Advanced Medical Devices</li><br><li>Global Advanced Medical Devices</li><br><li>Swiss Healthcare</li><br><li>Swiss Medical Products</li><br><li>European Healthcare</li><br><li>European Medical Products</li><br><li>European Ex. UK Healthcare</li><br><li>European Ex. UK Medical Products</li><br><li>Global Healthcare</li><br><li>Global Medical Products</li><br><li>US Advanced Medical Devices</li><br><li>Americas Advanced Medical Devices</li><br><li>Americas Healthcare</li><br><li>Americas Medical Products</li><br><li>US Healthcare</li><br><li>US Medical Products</li><br><li>North American Healthcare</li><br><li>North American Advanced Medical Devices</li><br><li>North American Medical Products</li><br></ul><br><em>Companies</em><br><ul><li>STMN.S Straumann</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Maja S. Pataki</author>
<category>STMN.S</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uer69968|native|public|20091119094930</guid>
<pubDate>Thu, 19 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[US Biotechnology  "Quarterly Treatment Tracker" 18-Nov-2009 Shenouda]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82787|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Biotechnology</li><br><li>Global Healthcare</li><br><li>US Biotechnology</li><br><li>Americas Biotechnology</li><br><li>Americas Healthcare</li><br><li>US Healthcare</li><br><li>North American Biotechnology</li><br><li>North American Healthcare</li><br></ul><br><em>Companies</em><br><ul><li>CELG.O Celgene</li><br><li>OSIP.O OSI Pharmaceuticals</li><br></ul><br><em>Subjects</em><br><ul><li>Industry Overview</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Maged Shenouda</author>
<category>CELG.O</category>
<category>OSIP.O</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82787|native|public|20091118212545</guid>
<pubDate>Wed, 18 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Medtronic "Warning letter shouldn't delay products" (Buy) Nudell]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82781|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Advanced Medical Devices</li><br><li>Global Healthcare</li><br><li>Global Medical Products</li><br><li>US Advanced Medical Devices</li><br><li>Americas Advanced Medical Devices</li><br><li>Americas Healthcare</li><br><li>Americas Medical Products</li><br><li>US Healthcare</li><br><li>US Medical Products</li><br><li>North American Healthcare</li><br><li>North American Advanced Medical Devices</li><br><li>North American Medical Products</li><br></ul><br><em>Companies</em><br><ul><li>MDT.N Medtronic</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Bruce Nudell, PhD</author>
<category>MDT.N</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82781|native|public|20091118170756</guid>
<pubDate>Wed, 18 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Pharmaceutical Services "Pharmaceutical Services: Green Light" 18-Nov-2009]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82784|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Healthcare</li><br><li>Americas Healthcare</li><br><li>US Healthcare</li><br><li>North American Healthcare</li><br></ul><br><em>Companies</em><br><ul><li>MCK.N McKesson</li><br><li>ABC.N AmerisourceBergen</li><br><li>CAH.N Cardinal Health</li><br><li>CVS.N CVS Caremark Corp.</li><br><li>ESRX.O Express Scripts</li><br><li>OCR.N Omnicare</li><br><li>MHS.N Medco Health</li><br><li>SXCI.O SXC Health Solutions</li><br><li>PMC.N PharMerica</li><br></ul><br><em>Subjects</em><br><ul><li>Change in Recommendation</li><br><li>Company Update</li><br><li>Industry Overview</li><br><li>Initiating Coverage</li><br></ul>]]></description>
<author>Steven Valiquette</author>
<category>MCK.N</category>
<category>ABC.N</category>
<category>CAH.N</category>
<category>CVS.N</category>
<category>ESRX.O</category>
<category>OCR.N</category>
<category>MHS.N</category>
<category>SXCI.O</category>
<category>PMC.N</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82784|native|public|20091118074300</guid>
<pubDate>Wed, 18 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Abbott Laboratories "Humira Monthly Rx" (Buy) Nudell]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82778|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Medical Supplies</li><br><li>Global Healthcare</li><br><li>Global Medical Products</li><br><li>Americas Medical Supplies</li><br><li>US Medical Supplies</li><br><li>Americas Healthcare</li><br><li>Americas Medical Products</li><br><li>US Healthcare</li><br><li>US Medical Products</li><br><li>North American Healthcare</li><br><li>North American Medical Supplies</li><br><li>North American Medical Products</li><br></ul><br><em>Companies</em><br><ul><li>ABT.N Abbott Laboratories</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Bruce Nudell, PhD</author>
<category>ABT.N</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82778|native|public|20091118144616</guid>
<pubDate>Wed, 18 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[First Read: Genzyme "Renal Franchise Facing Patent Cliff" (Neutral) Shenouda]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82777|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Americas</li><br><li>United States</li><br><li>North America</li><br></ul><br><em>Sectors</em><br><ul><li>Global Biotechnology</li><br><li>Global Healthcare</li><br><li>US Biotechnology</li><br><li>Americas Biotechnology</li><br><li>Americas Healthcare</li><br><li>US Healthcare</li><br><li>North American Biotechnology</li><br><li>North American Healthcare</li><br></ul><br><em>Companies</em><br><ul><li>GENZ.O Genzyme</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Maged Shenouda</author>
<category>GENZ.O</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uez82777|native|public|20091118133142</guid>
<pubDate>Wed, 18 Nov 2009</pubDate>
</item>
<item>
<title><![CDATA[Ryman Healthcare "New land to continue the growth" (Buy) Gardiner]]></title>
<link>http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uet11531|native|public</link>
<description><![CDATA[This document is related to the following:<br><em>Regions</em><br><ul><li>Global</li><br><li>Asia Pacific</li><br><li>Asia Pacific Ex. JP</li><br><li>New Zealand</li><br><li>Australasia</li><br></ul><br><em>Sectors</em><br><ul><li>Global Healthcare Providers</li><br><li>Global Healthcare</li><br><li>Asian Pacific Healthcare</li><br><li>Asian Pacific Healthcare Providers</li><br><li>Asian Pacific Ex. JP Healthcare</li><br><li>Asian Pacific Ex. JP Healthcare Providers</li><br><li>New Zealand Healthcare Providers</li><br><li>New Zealand Healthcare</li><br><li>Australasian Healthcare</li><br><li>Australasian Healthcare Providers</li><br></ul><br><em>Companies</em><br><ul><li>RYM.NZ Ryman Healthcare</li><br></ul><br><em>Subjects</em><br><ul><li>Company Update</li><br><li>Operating Results</li><br><li>Morning Note</li><br></ul>]]></description>
<author>Wade Gardiner</author>
<category>RYM.NZ</category>
<guid isPermaLink="false">http://research.ibb.ubs.com:80/servlet/SrchDoc?rss=uet11531|native|public|20091118043011</guid>
<pubDate>Wed, 18 Nov 2009</pubDate>
</item>
</channel>
</rss>
